Securities fraud litigation history and active cases
In Litigation
0
Settlement
0
Closed
1
Total Settlement
$0
5:20cv3432 • May 21, 2020
Class Period Start
May 17, 2018
Class Period End
May 13, 2020
PSLRA Deadline
July 20, 2020
Case Allegations
10b5
Statutes of Repose
May 17, 2021
Country
United States
Court
Federal Court
Jan 14, 2021
Voluntary Dismissal
The plaintiff in this action has chosen not to proceed with the case. Once a case is voluntary dismissed, the courts will usually close the case and no further action will be taken.
Dec 2, 2020
Scheduling Order
Nov 18, 2020
Appointment of Lead Plaintiff
The court has appointed a lead plaintiff to represent the interests of investors in the lawsuit. The lead plaintiff works with the attorneys handling the case, helps oversee the litigation, and represents the interests of the proposed class.
Jul 13, 2020
Scheduling Order
May 21, 2020
First Filed Complaint
A securities fraud class action complaint has been filed on behalf of certain investors in CytomX Therapeutics, Inc..
TOP
